Molecular Vision's Corporate Majority Round

Molecular Vision raised a round of funding on March 26, 2012. Investors include Abingdon Health.

Molecular Vision is an Imperial College spin-out company that develops low-cost diagnostic devices for use in the doctor's surgery and in the home. Its devices combine microfluidic chips with organic…

Articles about Molecular Vision's Corporate Majority Round: